| Pharmaceutical Information |
| Drug Name |
Lercanidipine |
| Drug ID |
BADD_D01255 |
| Description |
Lercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip. |
| Indications and Usage |
For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome |
| Marketing Status |
approved; investigational |
| ATC Code |
C08CA13 |
| DrugBank ID |
DB00528
|
| KEGG ID |
D08111
|
| MeSH ID |
C060343
|
| PubChem ID |
65866
|
| TTD Drug ID |
D0P6ZH
|
| NDC Product Code |
Not Available |
| UNII |
V7XTJ4R0BH
|
| Synonyms |
lercanidipine | methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | lercanidipine hydrochloride | Zanidip | Lerdip | Lercadip | REC 15-2375 | REC-15-2375 |
|
| Chemical Information |
| Molecular Formula |
C36H41N3O6 |
| CAS Registry Number |
100427-26-7 |
| SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+
](=O)[O-])C(=O)OC |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
